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ABSTRACT

The present invention provides methods and compositions
for preventing or inhibiting human food-borne pathogens in
animals, and methods for increasing feed efficiency in
animals by administering to the animal effective amounts of
probiotic lactic acid producing bacteria. Further provided
are feed compositions comprising probiotic lactic acid producing bacteria. A preferred probiotic lactic acid producing
bacteria is Lactobacillus acidophilus strain ATCC accession
number PTA-5249. This bacterial strain inhibits nalidixic
acid-resistant Escherichia coli 0157:H7.
6 Claims, 8 Drawing Sheets
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LACTIC ACID BACTERIA CULTURES THAT
INHIBIT FOOD-BORNE PATHOGENS
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Accordingly, there is growing consensus that control of
food-borne pathogens in live animals is the most effective
strategy for further reducing human food-borne illness.
CROSS REFERENCE TO RELATED
Toward that end, vaccination has been one approach
5 employed to protect animals from carriage of microorganAPPLICATION
isms causing food-borne illness in humans. Vaccines, howThis application claims priority from Provisional Appliever, are not entirely effective in reducing the carriage of
cation Ser. No. 601389,968 filed on Jun. 19, 2002, which is
human, food-borne pathogens because many of these pathohereby incorporated by reference in its entirety.
gens do not actually infect the animal, but merely reside in
l o the animal's intestinal tract. As a result, vaccination is
FIELD OF THE INVENTION
largely ineffective in preventing the slaughter-house contamination of meat intended for human consumption. FurThe invention relates to probiotic lactic acid bacteria used
ther diminishing the attractiveness of a vaccine based
to prevent or inhibit the carriage of human pathogenic
approach is the growing concern that the presence of antiorganisms in animals. More particularly, the invention 1s biotic resistant genes in vaccines is resulting in the develrelates to probiotic lactic acid bacteria selected for specific
opment of resistant populations of harmful bacteria.
characteristics useful in the prevention of carriage of human
~ ~ ~the ~use ~of competitive
t l ~ exclusion
,
products
pathogenic bacteria, including E. coli 0157:H7, in mature
( " c E ~ ) , such as probiotics, for inhibiting the carriage of
ruminant animals.
food-borne pathogens in live animals has shown significant
20 promise. Competitive exclusion employs the use of live
BACKGROUND OF THE INVENTION
microbial cultures that are not harmful to the animal and are
also not harmful to humans. These microbial cultures are
Food-borne diseases are an important public health conable to out
food-borne pathogens in the animal's
tern. In the United States
the Occurrence
intestinal tract and prevent pathogens from colonizing. The
borne illness is estimated to be between 6 and 80 million 25 use .fa CEP based approach is thus promising, because
illnesses with approximately 9000 deaths annually. The
unlike the vaccine based approach, CEPs are able to benmost prevalent agent causing food-borne illness is Campyeficially alter the microflora in the intestinal tract of the
lobacter jejuni. This agent alone is estimated to be responanimal thereby reducing or eliminating the carriage of
sible for causing 4 million of these cases with more than
harmful human pathogens,
1000 deaths annually. Although less prevalent than Campy- 30
probiotics, as discussed above, are an important class of
lobacter jejuni, Salmonella (non-typhoid) is also a major
CEP that have been reported to inhibit many food-borne
health concern because it is responsible for 2 million cases
pathogens including Escherichia coli, Campylobacter
disease and
2000 deaths each year. Further,
jejuni, Salmonella, and Listeria monocytogenes, Many
more than 25,000 of these cases with more than 200 deaths
classes of microorganisms are employed as probiotics
annually have been attributed to food-borne Escherichia 35 including yeasts such as Saccharomyces and Torulopsis,
Coli 0157:H7. And while the incidence of disease due to E.
fungi such as Aspergillus, and microorganisms belonging to
"li
is much
rare than many other foodthe genera Bacillus and Clostridium have also been used.
borne pathogens, such as Salmonella and Campylobacter, it
Intestinal strains of lactic acid bacteria, however, are the
is a particular concern because it is often life-threatening in
most widely utilized class of microorganisms as probiotics.
children and the elderly.
40
Lactic acid bacteria are widely employed as probiotics
Equally, in addition to the staggering health concerns
because members of this
group are particularly
associated with food-borne illness, is the severe economic
suitable as antagonistic microorganisms in food due to their
burden these agents cause. This economic burden is not
ability to inhibit other food-borne bacteria coupled with their
limited to one specific area of the economy, but stretches
ability to be used safely. For example, Nisbet et al. (U.S. Pat.
through several sectors. For example, human health costs 45
No. 5,340,577) reported the reduction of Salmonella conassociated with food-borne illness is estimated to be
centration in fowl using a probiotic mixture containing
approximately 22 billion dollars annually in the United
several lactic acid bacteria. Despite these advantages and
States alone. Equally devastating are the somewhat intanS U C C ~ S S ~use
U ~ in fowl, however, lactic acid bacteria have not
gible costs incurred by the livestock industry, such as
been employed as a means to reduce the carriage of foodtreatment costs and livestock deaths, negative public per- 50
borne pathogens in mature ruminant
ception, increased cull rates, reduced feed efficiency, and
Accordingly, a need exists for a probiotic containing lactic
decreased weight gain.
acid bacteria effective in treating or preventing the carriage
~
~have been
i identified
~
as ~a major l source ~of these
of food-borne pathogens in mature ruminant animals. The
food-borne illnesses when humans consume meat and other
55 present invention addresses this need by providing strains of
products contaminated with m~croorgan~sms
at slaughter,
lactic acid bacteria that may be safely and economically
particular, the deadly food pathogen, E, coli 0 1 5 7 ~ ~ 7is,
employed as ~robioticsin mature ruminant animals.
predominantly found in the intestinal tract of cattle. Food
processors and government agencies have responded to this
SUMMARY OF THE INVENTION
problem by instituting hazard analysislcritical control point
(HACCP) models to provide food safety assurance. In fact, 60
this program is required by the USDA in most meat and
Among the several aspects of the invention, therefore, is
poultry processing facilities. HACCP systems are designed
provided a method of preventing or inhibiting the carriage of
to systematically prevent food safety hazards from occurhuman food-borne pathogens in mature ruminant animals by
ring. While HACCP has resulted in a decreased risk of
administering a probiotic lactic acid bacteria specifically
contamination during the post-harvest period, it does not 65 selected for certain characteristics, including survivability in
address the issue of contamination caused in the pre-harvest
the gastrointestinal tract, adhesiveness to intestinal epitheperiod.
lium, antibiotic susceptibility, and technological properties.
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Another aspect of the present invention provides a method
for increasing feed efficiency in a mature ruminant by
administering to the animal an effective amount of a composition comprising a probiotic bacterial strain. Further
provided are feed compositions comprising the probiotic
bacterial strain.
Other features of the present invention will be in part
apparent to those skilled in the art and in part pointed out in
the detailed description provided below.

FIG. 8 is a graphic representation of incidence of E. coli
0157:H7 in cattle that received treatment with a CEP. This
figure is described in more depth in example 13.
5
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BRIEF DESCRIPTION OF THE DRAWINGS
These and other features, aspects, and advantages of the
present invention will become better understood with regard
to the following description, appended claims and accompanying figures where:
FIG. 1depicts the nomenclature of isolates based on diets,
sample collection from cattle at 3, 6, 9 and 12 weeks, and
number of isolates from each sample, The letters A through
represent each animal in a diet group from which fecal
samples were collected, p1 through p4 represent the tirne
periods at which samples were collected; P1 represents the
first 3-week interval, P2 represents the second 3-week
interval, P3 represents the third 3-week interval, and P4
represents the fourth 3-week interval (for a total of 12
weeks). All-T415 represent isolated colonies, with each
colony collected from a given animal (A through
at a
given period of time (PI through P4). For example, A215
represents isolate number 15 obtained during the second
3-week interval from animal A.
FIG. 2 is a graphic representation of inhibition of E. coli
0157:H7 using the agar spot test, as further described in
Example 2, by strains isolated from cattle fed 3 different
diets: corn gluten feed diet, dry rolled corn diet, high
moisture corn diet.
FIG. 3 is a graphic representation of inhibition of E. coli
0157:H7 by several different lactic acid bacteria strains in
manure. These strains and the interaction test are described
in more depth in example 7 and in the examples accompanying tables. The control sample contained only the E. coli
0157:H7 strain. Bars with different letters are sianificantlv
(Pe0.05) different.
FIG. 4 is a graphic representation of inhibition of E. coli
0 1 57:H7 by lactic acid bacteria in rumen fluid. These strains
and the interaction test are described in more depth in
and in the
The
control sample contained only the E. coli 0157:H7 strain.
Bars with different letters are significantly (Pe0.05) different.
FIG. 5 is a graphic representation of inhibition of E. coli
0157:H7 by competitive exclusion product (CEP) in
manure. UNL represents a mixture of isolates M35 (ATCC
accession no. PTA-5249) and LA45. NPC represents a
mixture of commercial strains LA51 and LA45. The control
sample contained only the E. coli 0157:H7 strain.
FIG. 6 is a graphic representation of inhibition of E. coli
0157:H7 by competitive exclusion product (CEP) in rumen
fluid. UNL represents a mixture of isolates M35 (ATCC
accession no. PTA-5249) and LA45. NPC represents a
mixture of commercial strains LA51 and LA45. The control
sample contained only the E. coli 0157:H7 strain.
FIG. 7 is a graphic representation of incidence of E. coli
0 1 57:H7 in 180 cattle (60ltreatment) after treatment with a
competitive exclusion product (CEP). The CEPs, 747 and
750, as well as the control are described in more depth in
example 13.
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ABBREVIATIONS AND DEFINITIONS
TOfacilitate understanding of the invention, a number of
terms and abbreviations as used herein are defined below:
"CGF" stands for corn gluten feed.
"d" stand for days.
"DRC" stands for dry rolled corn diet.
"Enteropathogenic" shall include a microorganism
capable of causing disease in the intestinal tract.
"Food-borne Pathogenic Bacteria" shall include a microo ~ a n i s mthat is pathogenic to humans when present in food
that is consumed by a human.
"HMC" stands for high moisture corn diet.
"h" stands for hour.
The term "inhibition" when used herein in phrases such as
"carriage inhibition" or "inhibition of carriage" means a
decrease in growth, in terms number target bacteria, as
to the growth Or concentration that
occur in
the absence of the application of the method of the invention.
"lb" Stands for pound.
"Mature Ruminant" shall include a ruminant having a
stomach wherein all four compartments are functioning.
"Probiotic" shall include a mono- or mixed culture of live
microorganisms which,
to a man Or
(e.g., as
dried cells or as a fermented product), affects beneficially the
host by improving the properties of the indigenous microflora.
"Ruminant" shall include mature and immature animals
with multi-compartment stomachs, including but not limited
to, cattle, sheep, deer, goats, musk, ox, buffalo, giraffe and
camels. For example, cattle and sheep have a stomach with
four compartments comprising the rumen, reticulum, omssum, and abomasum,
DESCRIPTION OF THE PREFERRED
EMBODIMENTS
An efficient, safe, and economical method to prevent or
treat the carriage of food-borne, pathogenic bacteria in
mature ruminant animals has been discovered, This method,
.dike previous approaches, advantageously comprises
administering to the mature ruminant an effective amount of
a probiotic containing one to several strains of lactic acid
bacteria ("LAB"), LAB, as previously stated, are particularly beneficial for use as a probiotic due to their ability to
inhibit other food-borne bacteria coupled with their ability to
be used safely in food to be consumed by humans. Several
strains of LAB that are suitable for use as a probiotic to
prevent or treat the carriage of food-borne, pathogenic
bacteria in mature ruminant
have been discovered,
The probiotics employed in the present invention, as
stated above, generally prevent or treat the carriage of
food-borne, pathogenic bacteria in ruminant animals, It is
believed, without being bound by any particular theory, that
the probiotics employed in the invention act by competitive
exclusion ("CW). Competitive exclusion is the use of live
microbial cultures that exhibit antagonistic effects against
specific groups of organisms, such as food-borne pathogens,
resulting in the overall decrease in numbers of the pathogen
in the intestinal tract. Although not well studied, the mechanisms by which competitive exclusion products exclude
pathogens from the intestinal tract that have been observed

5
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include: (1) production of antibacterial agents (bacteriocins)
(c) Antibiotic Susceptibility
and primary metabolites (organic acids and hydrogen perIt is believed that antimicrobials used in food-producing
oxide) that may inhibit pathogenic microflora; (2) competianimals can promote the emergence of resistance in probition for nutrients; and (3) competition for adhesion sites on
otics that can lead to transfer of resistance to other pathothe gut epithelial surface that may prevent colonization by 5 genic bacteria by exchange of genetic material, or it can
pathogenic microorganisms.
increase the potential threat posed by these organisms as
Typically the probiotic may be administered to a number
opportunistic pathogens. In one embodiment, therefore, the
of different animals. In general, however, probiotic LAB are
LAB is not resistant to antibiotics. In another embodiment,
host specific. Thus, for example, Lactobacillus isolated from
the LAB is typically not resistant to more than 4 of the
a specific site of a specific animal source typically colonizes l o following antibiotics: erythromycin, tetracycline, ampicillin,
epithelium of the same kind. Generally, therefore, LAB are
grepafloxicin, levofloxacin, trimthoprimisulfamethoaxoisolated from an animal species and administered as a
zole, vancomycin, cephalothin and polymixin B. In yet
probiotic to an animal from the same species. In one
another embodiment, the LAB is not resistant to more than
embodiment, LAB are isolated from mature ruminants for
2 of the above-identified antibiotics. In still another embodiuse as probiotics in mature ruminants. It is, however, also 1s ment, the LAB is not resistant to any of the above-identified
envisioned that LAB may be isolated from a variety of
antibiotics; and
livestock animals, including but not limited to, fowl, equine,
(d) Technological Properties
ruminants and porcine and administered as a probiotic to the
The probiotic LAB generally undergoes several processparticular animal species. The methods described herein
ing steps before use as a feed supplement. Such processing
enable one skilled in the art to isolate the corresponding 20 steps may involve, separation by centrifugation or filtration,
probiotic LAB in a target animal. Equally, any known
fermentation in cultured products, and freeze-drying or
method for bacterial isolation, modified for mature ruminant
lyophilization. Therefore, the LAB should be able to withanimals, may be employed, such as, for instance, methods
stand stresses associated with these procedures such as
described in Buck, L. M. and S. E. Gilliland., Comparisons
freezing, high pressure and temperatures (60-80" C. for 5-10
of freshly isolated strains of Lactobacillus acidophilus of 25 minutes during pelleting) and should have a high growth rate
human intestinal origin for ability to assimilate cholesterol
and achievable cell mass. In addition, the LAB should be
able to retain its viability under storage conditions.
during growth. J. Dairy Sci. 77: 2925, 1994.
The probiotics employed in the present invention typiLAB bacteria possessing the desired characteristics
cally comprise from one to several strains of LAB. In one
described above may be employed as a probiotic in the
embodiment, the probiotics comprise from one to ten dif- 30 present invention. Typically, however, the LAB is selected
ferent strains of LAB. In yet another embodiment, the
from among the genera Lactobacillus, Lactococcus, Leuprobiotic comprises from two to five different strains of
conostoc, Pediococcus, Enterococcus and Streptococcus. In
LAB. In still another embodiment, the probiotic comprises
one embodiment the LAB employed as a probiotic is from
more than ten different strains of LAB.
the genera Lactobacillus. In yet another embodiment, the
In general, LAB constitute a group of Gram-positive 35 strain of Lactobacillus is selected from L. acidophilus, L.
bacteria that share similar morphologic, metabolic and
bulgaricus, L. helveticus, L. casei, L. lactis, L. plantarum, L.
physiologic characteristics. These bacteria are non-spore
rhamnosus, L. reuteri, L. fermentum, L. brevis, L. delbreukii,
forming rods and cocci that ferment carbohydrates forming
L. cellobiosus, and L. salivarius.
lactic acids as the major end-product, hence giving way to
In yet another embodiment, the probiotic comprises a
the name LAB. Depending on the metabolic pathways used 40 LAB strain isolated based upon the criteria set forth above
to ferment carbohydrates and the resulting end products,
and depicted in the examples below. This strain has been
LAB are divided into two major groups, homofermentative
identified as L. acidophilus M35 (also referred to herein as
or heterofermentative. They are generally catalase-negative,
M35 only)(ATCC accession no. PTA-5249).
anaerobic in nature, non-motile and do not reduce nitrate.
The probiotic can be administered to the animal by a
LAB are widespread in nature with distribution common in 45 method likely to introduce the LAB into the digestive tract.
milk and dairy products, other fermented foods, intact and
In one embodiment, lyophilized LAB is thawed and mixed
rotting vegetable material, silage and intestinal tracts and
with the animal's feed or drinking water. Lyophilization
mucous membranes of man and animals.
(freeze-drying) can be performed by freezing a bacterial
Typically, for a LAB to be a useful probiotic to prevent or
culture and concentrating it under vacuum to sublime the
treat the carriage of food-borne, pathogenic bacteria in 50 water from the frozen preparations. Briefly, cells are harmature ruminant animals, the bacteria are typically isolated
vested by centrifugation, resuspended in lyophilization
from mature ruminant animals and are selected so that they
media and frozen at -70' C. in lyophilization vials. Vials are
possess certain characteristics. In the present invention, the
then placed on the lyophilizer and lyophilized for, e.g., 3
LAB employed as a probiotic typically have the following
hours at e.g., Itoreq 20 millitorrs and -100" C. The vials are
features:
55 next sealed and stored at refrigerated or freezer temperatures
(a) Survival in the Gastrointestinal Tract
until rehydration. Modifications to this protocol, depending
The probiotic LAB of the present invention should be able
on the cells to be lyophilized, can be easily made by one of
to survive and metabolize in the intestine of the mature
ordinary skill in the art.
ruminant. This means that the strain is typically resistant to
It should be noted that several factors play a role in
gastric acid juices, low pH, enzymes, organic acids and bile 60 viability and storage time of lyophilized bacteria. First, at
and pancreatic secretions;
the time of harvesting, it is preferable that the cultures are
(b) Adhesion to Intestinal Epithelium
healthy and actively growing in either the logarithmic or
The probiotic LAB of the present invention should have
early stationary phase, and have a density of about 108/ml.
good adhesion properties to the intestinal cells of the mature
It is also important that the medium for cell preservation
ruminant thereby enhancing colonization of the LAB. Adhe- 65 contains a cryoprotective reagent, such as, e.g., skim milk,
sion is also desired to prevent the LAB from being washed
sucrose, serum, inositol, or dextran. However, it should also
away by contents of the stomach, intestine and by peristalsis;
be noted that the selection of media and cryoprotective

US 7,323,166 B2
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agents is an empirical process that depends on bacterial cells
to be lyophilized. A skilled artisan can easily determine
optimal lyophilization conditions for particular bacteria. In
addition, methods for preserving cells, including the lyophilization methods are numerous and well known in the art.
See, for instance, Maintenance of Microorganisms, Kirsop,
B. E., and Snell, J. J. S., Eds., (1984), Academic Press, New
York). Alternatively, lyophilization of bacteria is commercially available.
In another embodiment, the LAB is mixed with a carrier
and applied to liquid or solid feed or to drinking water. The
carrier material should be non-toxic to both the LAB and the
animal. The carrier will generally contain an ingredient that
promotes viability ofthe LAB during storage, When administered in feed or drinking water the dosage can be spread
over a period of days or even weeks. In yet another embodiment, the LAB is formulated as an inoculant paste to be
directly injected into an animal's mouth. The formulation
can include additional ingredients to improve palatability,
improve shelf-life, impart nutritional benefits, and the like.
In still a further embodiment, if a reproducible and measured
dose is desired, the LAB can be administered by rumen
cannula.
The effective amount of probiotic administered to the
animal is a quantity to achieve the desired carriage inhibition
of food-borne, pathogenic bacteria. This effective amount
can vary depending on many factors, such as, the size of the
animal, the species of the animal, the age of the animal, the
particular active compound used, the dosage form employed
or the particular sensitivity of the particular animal. The
optimum range of an effective amount, based on variables
such as those mentioned above, can be found using conventionally known techniques, for example, such as, dose
titration determinations or any other method generally
known in the veterinary sciences. For example, by monitoring the numbers of target pathogen in the feces before,
during and after administration of probiotic, the skilled
artisan can readily ascertain the dosage level.
In one embodiment, the probiotic is administered as a
preventative, to prevent animals not presently carrying the
pathogen from acquiring the strain by exposure to other
animals or environments where the pathogen is present. In
yet another embodiment, the probiotic is administered to
treat animals carrying a pathogen. For example, animals
known to be shedding a pathogen in feces, or those raised
where a pathogen is known to exist are suitable candidates
for treatment with probiotic. The methods for administering
probiotic are essentially the same, whether for prevention or
treatment.
The probiotic LAB of the present invention may be
administered to a mature ruminant to prevent or treat the
carriage of a number of target food-borne, pathogenic bacteria for which the probiotic is effective against. In general,
the term "food-borne, pathogenic bacteria" means that the
bacteria is pathogenic to humans. Depending on the particular strain of LAB utilized, however, the probiotic may also
be effective against bacteria that are pathogenic to the host
animal, such as mature ruminant animals. In one embodiment, the target food-borne, pathogenic bacteria is a strain of
human enteropathogenic bacteria. In yet another embodiment, the human enteropathogenic bacteria is selected from
Campylobacter jejuni, Salmonella, Escherichia coli, Listeria monocytogenes, and Vibrio. In still another embodiment, the target bacteria is Escherichia coli. In yet another
embodiment, the target bacteria is E. coli 0157:H7.

EXAMPLES

5

It is understood that the foregoing examples are given by
way of illustration and that modifications and variations may
be made therein without departing from the spirit and scope
of the invention.
Example 1
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Isolation of Strains of LAB From Healthy Cattle
Cattle that were fecal culture negative for E. coli 0 1 57:H7
were
for
LAB
that were to be screened for inhibitory activity towards E.
coli 0157:H7. Manure sample from the Animal Science
Department of University of Nebraska-Lincoln (UNL) were
obtained at three-week intervals over a period of twelve
weeks (4 sampling periods) from cattle that were fed three
different finishing diets, (1) High Moisture Corn (HMC), (2)
Dry Rolled Corn (DRC), and (3) Corn Gluten Feed (CGF)
(Table 1). Samples were collected separately from 5-7 cows
from each diet group and numbered as illustrated in FIG, 1,
One gram of each fecal sample was added to
ml of
sterile de Man-Rogosa-Sharpe (MRS) broth (Difco Becton
Dickinson Microbiology Systems, Sparks, Md,) and mixed
thoroughly by shaking. The fecal material was then plated
on Lactobacillus Selection (LBS) agar (BBL Becton Dickinson Microbiology Systems, Cockeysville, Md.) and MRS
agar plates using the streak-plate method. The plates were
incubated at 37O C. for 48 hours in plastic bags flushed with
CO, for 30 seconds. Approximately 10 to 15 well-isolated
colonies were picked from each plate and transferred to
individual tubes containing 10 ml of MRS broth, which were
further incubated at 37' C. for 18-72 hours to obtain
maximum growth of the cultures. The isolated cultures were
restreaked onto LBS and MRS agar plates and incubated at
37O C. for 48 hours. This process was repeateduntil only one
colony morphology appeared. Following isolation, pure
colonies were Gram-stained according to the Bergey's
Manual of Determinative Bacteriology (Sneath P. H. A,, N.
S. Mair, M. E. Sharpe, and J. G. Halt (ed.), Bergey's Manual
of Systematic Bacteriology, Williams and Wilkins, MD.) for
preliminary identification. The isolated cultures were maintained as frozen (-70" C.) stocks in MRS broth supplemented with 10% (v/v) sterile glycerol. Isolates were subcultured in MRS broth at 37' C. for 24-48 hours before they
were used for further studies.
TABLE 1

50

Composition of diets fed to cattle
utilized for isolation of bacteria
HMC

Ingred~ent"
55

A...I ..-~
.

~

I

~

~

Molasses
~upplemental"
HMC
DRC
CGF

DRC

CGF

7.
50%
.

75
50%
..
.

7 50%

3.0%

3.0%

5.0%
84.5%

5.0%

5.0%

-

-

-

84.5%

-

-

47.5%
40.0%

60

HMC - High Moisture Corn; DRC - Dry Rolled Corn; CGF - Corn Gluten
?$matter
basis
"pmtein mineral and "itamins
65

Six hundred eighty-six isolates were obtained; 15% were
Gram-negative and 85% were Gram-positive bacteria with
72% Gram-positive rods and 27% Gram-positive cocci, as

US 7,323,166 B2
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determined by the Gram-staining procedures followed by
microscopic examination. Isolates were obtained from all
animals on all diets.

oxgall or without oxgall (control). The inoculated tubes were
incubated at 37' C. in a water bath. Growth of the organisms
was monitored at 0, 2, 4, 6, and 24 hours by measuring
absorbance at 660 nm. The test for each strain was repeated
three times.
Bile tolerance studies indicated that all isolates except
A22 showed increased growth rate under all bile conditions
(0. 0.5, 0.15, and 0.30%). However, when compared with
other treatments, the growth was slightly decreased for
treatment containing 0.3% oxgall but showed a gradual
increase over a 24 hour period with the following exceptions: (i) strains C l l l and M38 showed reduced growth for
0.3% oxgall at 24 hours, and (ii) strains F111, T28, 4311,
and J49 did not grow well at 0.3% oxgall at all incubation
periods,

Example 2

5

Screening Isolated Colonies for Inhibition Towards
E. coli 0157:H7
Isolated strains were initially screened for inhibition
towards E. coli 0157:H7 using the agar spot test. An
overnight culture of each cattle isolate to be tested was
prepared by inoculating stock culture in 10 ml of MRS
broth. Cultures of individual strains were then spot-inoculated onto the surface of MRS agar plates and incubated for
24-48 hours at 37' C. in plastic bags flushed with CO, for 30
seconds. A four-strain mixture of E. coli 0157:H7 was used
to screen the isolates for inhibitory activity towards E. coli
0157:H7. The E. coli strains used in the study were originally obtained from the laboratory of Charles Kaspar (Food
~ e s k a r c hInstitute, University of Wisconsin, adi is on, is.)
and included strains 920, 922, 944, and 966 (all cattle
isolates). Overnight cultures of E. coli strains were prepared
(5x108 CFU1ml)
l o m1 t ~ ~ t i c
(TSB) (Difco Becton Dickinson Microbiology Systems,
'parks, Md.) with
stocks of each E. "li
(-700
strain and incubating at 37' C. for 18-24 hours.
numbers were determined
pour-plating each
On try~tic
agar (TSA) (DifcO), using
appropriate dilutions, and incubating at 37' C. for 18 hours.
The cocktail of E. coli 0157:H7 was prepared by placing 1
ml of the overnight culture of each strain into a sterile
test-tube and thoroughly mixing. About 1 ml of the cocktail
mixture was inoculated into 10 ml of tempered soft TSA to
obtain a final concentration of approximately 5x107 CFUI
ml. This mixture was then poured onto the surface of
spot-inoculated agar plates that contained well-grown test
isolates. After 24 hours of incubation at 37' C., inhibitory
activity of the test isolate was measured as the size of
inhibition zones around the colony, inhibition was considered significant when the width of the clear zone around the
colonies of the isolated strains was 0.5 mm or larger. The test
for each isolate against the pathogen cocktail was replicated
three times.
All 686 isolates were tested for inhibition towards E, coli
0157:H7 using agar spot test. Three hundred fifty-five
isolates (52%) met or exceeded the inhibition criteria (inhibition zone 20.5 mm) and 275 isolates (40%) produced
inhibition zones near or greater than 1 mm. The inhibition
zones ranged from 0.5 mm to as large as 12 mm. Results are
shown in FIG. 2. In addition, for specific values of a number
of isolates, see Table 3 (inhibition column).

10

15

Example 4
Storage Stability
20

25

30

35

40

45

hours,
At the end of all the screening procedures (24 months),
the isolates finally selected as competitive exclusion products (CEP) were tested for viability by plating concentrated
cultures on MRS agar (at appropriate dilutions) and incubating at 37O C. for 18-24 hours. Colonies were counted after
incubation to determine the actual population.
All isolates maintained their viability over a period of 3
months of storage at 0' C. with the exception of isolates A43
andA46 that did not survive storage in a commercial freezer.
Isolates M35 (ATCC
PTA-5249) and L41 that
were
as CEP showed good
after 24 months
of storage at -70' C. A population of about lxlo9 CFUIml
was obtained for both the isolates after culturing on MRS
agar.
Example 5

50

Example 3
55

Test for Bile Tolerance
The isolates that were most inhibitory towards E, coli
0 1 57:H7 in the agar spot test were selected for bile tolerance
tests. The method used for testing bile tolerance was similar
to the one described by Gilliland et al. (Gilliland, S. E.,
Stanley, T. E., and Bush, L. J. 1984. Importance of bile
tolerance of Lactobacillus acidophilus used as a dietary
adjunct. J. Dairy Sci. 67: 3045-3051). An overnight culture
of the selected isolates was prepared in 10 ml MRS broth
and 0.1 ml of the culture suspension was inoculated into
tubes containing 10 ml MRS broth with 0.5, 0.15, 0.3%

Nineteen of the 75 isolates selected for further studies
were tested for storage stability in a commercial freezer (0"
C.). Following isolation, an overnight culture of each isolate
was prepared in MRS broth and supplemented with 10%
(vlv) sterile glycerol. About 1 ml of each culture was then
dispensed into sterile 1.5 ml cryogenic vials and frozen at
-70" C. These frozen stocks were transferred the next day to
a freezer set at 00 C, Viability of the isolates was tested at 0,
and after 3 months of storage in the commercial freezer by
plating on MRS agar and incubating at 370 C, for

60

65

Preliminary Identification of Isolates Using
Analytical Profile Index (API)
Based on their inhibitory activity towards E. coli 0157:
H7, and tolerance to acid and bile, 75 isolates were chosen
for identification by fermentation patterns using standard
API (bioMkrieux, Inc., Hazelwood, Mo.) tests. API SOCHL,
API 20Strep, and API 20E were used to identify Grampositive rods, Gram-positive cocci and Gram-negative rods,
respectively.
Based on the API, some of the isolates were eliminated
because either their identification was not clear (unacceptable or doubtful profile) or they were not LAB. The most
commonly identified strains of LAB according to API were:
Lactobacillus acidophilus, L. fermentum, L. delbreukii, L.
salivarius, L. brevis, L. cellobiosus, Leuconostoc spp., and
Pediococcus acidilactici (Table 2). Of the 75 isolates identified and screened for bile tolerance, 19 were selected for

US 7,323,166 B2
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further interaction studies in the manure and rumen fluid. A
list of the selected isolates along with their API profiles is
given in Table 3.

Example 6
Test for Antibiotic Resistance

TABLE 2
Identification of cattle
isolates bv Analflical Profile Index
Cattle
Isolate

API Used

Identification"

M17
KllO
H27
I212
~ 2 1
T28
C314
I33
M35
037
B41
L411
T21"
P32
A43
A46
C315
M38
S310
R44

50
50
50
50
50
50
50
50
50
50
50
50
20
50
50
50
50
50
50
50

L. fermentum
L. brevis
L. delvreukii ss. delb.
L. salivanus
L. brevis
L. acidophilus
L. acidophilus
L. brevis
L. acidophilus
L. cellobiosus
L. fermentum
L. acidophilus
Leuconostoc spp.
L. brevis
L. acidophilus
L. acidophilus
Pediococi acidilactici
L. acidophilus
L. acidophilus
L. acidophilus

CHL
CHL
CHL
CHL
CHL
CHL
CHL
CHL
CHL
CHL
CHL
CHL
strep
CHL
CHL
CHL
CHL
CHL
CHL
CHL

% Homology

91.5
99.7
88.5
99.9
99.5
82.5
88.3
99.5
98.5
97.2
98.9
84,2
98.3
99.4
87.5
99.2
99.8
95.8
60.3
95.8

lo

15

antibiotics used in the present study included erythromycin
(EM), ampicillin (AM), tetracycline (TC), trimethoprind
sulfamethoxazole (TS), grepafloxacin (GP) (quinolone), and
20

25

"Identification to genus level only

30

TABLE 3
Cattle isolates chosen for further analysis
based on inhibition" towards E. coli 0157:H7, Gram
reaction. bile tolerance" and Analvtical Profile Index

Isolate

Inhibition
(mm)

C315
A46
C314
M35
M3 8
S310
B41
R44
1212
037
L411
H27
A43
P3 1
C312
T2 1
T28
I33
P32

11.47
8.87
8.13
6.00
4.33
4.20
3.45
3.15
2.89
2.78
2.03
1.71
1.65
1.45
1.39
1.07
1.03
1.01
.97

35

Gram R X ~ .

API

cocci+
Rods+
Rods+
~ods+
Rods+
Rods+
Rods+
~ods+
~ods+
~ods+
Rods+
Rods+
Rods+
Rods+
~ods+
Cocci+
Rods+
~ods+
~ods+

PediOcOccusacidilactici
L. acidophilus
L. acidophilus
L. acidoahilus
L. acidophilus
L. acidophilus
L. fermentum
L. acidophilus
L. salivanus
L. cellobiosus
L. acidophilus
L. delbreukii. delbreukii
L. acidophilus
L. acidophilus
L. acidophilus
Leuconstoc spp.
L. acidophilus
L. brevis
L. brevis

The isolates selected after API results were further
screened for resistance to a panel of 6 antibiotics representing two of the three categories of antimicrobial drugs
suggested by FDA, that are commonly used in animals and
humans. The following are examples of types of drugs that
would be included in the three categories: Category I:
quinolones, vancomycin, dalfopristidquinupristin, third
generation cephalosporins; Category 11: ampicillin, first and
second generation cephalosporins, erythromycin, trimethoprindsulfamethoxazole; and Category 111: inophores (monensin) and polymixins (Polymixin B and colistin). The

levofloxacin (LE) (fluoroquinolone). A commercial antimicrobial susceptibility test kit-Etest (AB Biodisk, North
America Inc., Piscatway, N.J.) was used to determine the
minimum inhibitory concentrations (MIC) of the antibiotics
for the isolates selected. Etest strips containing a predefined
exponential gradient of a particular antibiotic were applied
to agar plates containing Mueller Hinton Agar (Difco)
pre-inoculated with an overnight culture of the given bacteria (inoculum of 0.5 McFarland turbidity in 0.85% NaCl).
The agar plates with the strips were immediately incubated
at 37" C. for 16-20 hours, when bacterial growth became
distinctly visible. After incubation, MIC values (pglml) were
read where the inhibition ellipse (centered along the strip)
intersected the scale at the edge of the strip. The susceptibility categorization of organisms towards a specific antibiotic was provided in the Etest antibiotic supplements for
each agent and was used to examine the susceptibility of
lactic acid bacteria (LAB) isolates. Based on the cateaorization, MIC for a particular organism was reported as
susceptible (S), intermediate (I), or resistant (R). The susceptibility categories of each antibiotic are given in Table 4.
When growth
occurred along
- the entire st&, i.e. no inhibition ellipse was seen, the MIC was reported as greater than
\

40

-

,

(>H) the highest value on the reading scale. When the

,, inhibition ellipse was below the strip, i.e. the zone edge did

7 d

50

"Agar Spot Test: Inhibition measured as the size of clear zone (in mm)
55
around the colony
"Bile tolerance not shown. All isolates were resistant to all bile conditions.

not intersect the strip, MIC was reported as less than (<L) the
lowest value on the reading scale.
Of the 19 strains tested, 21% (4 of 19) (M35 (ATCC
accession no. PTA-5249).
,, A43. C312. and 1212) showed
susceptibility to all the antibiotics. Most isolates were resistant to trimethoprindsulfamethaxozole and grepafloxacin
(63% and 58% respectively). Thirteen of 19 isolates (68%)
showed multiple resistance (22) patterns most commonly to
trimethoprindsulfamethaxozole, grepafloxacin, and tetracycline. Only one isolate (B41) was resistant to levofloxacin
and two isolates (T28 and C314) were resistant to ampicillin.
Results are shown in Tables 4 and 5.
TABLE 4
Minimum inhibitory concentrations
( d m I) of antibiotics" for cattle isolates

Isolates
I33
037

EM
3.00 (I)
0.14 (S)

TS
0.44 (S)
>H (R)

GP
1.2 (I)
9.0 (R)

AM
0.03 (S)
0.75 (S)

LE
2.3 (I)
3.0 (I)

TC
56.0 (R)
2.5 (S)
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TABLE 4-continued
Minimum inhibitory concentrations
( d m I) of antibiotics" for cattle isolates
Isolates

EM
>H
0.16
>H
0.11
<L
<L
0.11
<L
0.11
>H
0.24
8.00
<L
0.22
0.06
0.22
0.13

TS
(R)
(S)
(R)
(S)
(9
(9
(S)
(9
(S)
(R)
(S)
(R)
(9
(S)
(S)
(S)
(S)

>H
>H
>H
>H
1.50
<L
>H
<L
>H
6.19
>H
0.2
<L
>H
0.75
>H
>H

GP
12.0
6.0
12.0
7.5
0.10
<L
7.0
<L
8.0
6.25
1.0
2.25
<L
7.0
0.56
6.0
4.5

(R)
(R)
(R)
(R)
(S)
(9
(R)
(9
(R)
(R)
(R)
(S)
(9
(R)
(S)
(R)
(R)

AM
(R)
(R)
(R)
(R)
(S)
6')
(R)
6')
(R)
(R)
(S)
(I)
6')
(R)
(S)
(R)
(R)

0.87
0.87
1.12
0.87
48.0
0.50
0.87
<L
0.09
>H
0.56
0.11
<L
1.13
0.02
0.75
0.75

LE

(S)
(S)
(S)
(S)
(R)
(S)
(S)
(9
(S)
(R)
(S)
(S)
(9
(S)
(S)
(S)
(S)

2.5
2.0
2.0
1.5
0.1
<L
2.0
<L
3.0
2.3
17.5
3.0
<L
2.25
0.62
2.0
1.5

TC
(I)
(S)
(S)
(S)
(S)
6')
(S)
6')
(I)
(I)
(R)
(I)
6')
(I)
(S)
(S)
(S)

>H
1.75
32.7
1.2
1.5
<L
2.0
<L
2.0
30
>H
>H
<L
1.9
0.2
1.5
1.3

(R)
(S)
(S)
(S)
(S)
(9
(S)
(9
(S)
(R)
(R)
(R)
(9
(S)
(S)
(S)
(S)

"EM = Erythromycin; TS = Trimethoprim/Sulfmthoxazole; GP = Grepafloxacin; AM =
Ampicillin; LE = Levofloxacin; TC = Tetracycline; H = Highest MIC value on the scale;
256 g/ml for EM, AM, TC and 32 glml for TS, GP, LE; L = Lowest MIC value on the
scale

Susce~tibilitvCategorization of Antibiotics (MIC in g/m I):
Susceptible (S)
EM
TS
GP
AM
LE
TC

Intermediate (I)

Resistant (R)

8
1-4
4
16
2

16
8
8
32
4
4

4
0.5
2
8
1
2

-

30

35

40

TABLE 5
Test of antibiotic resistance in
cattle isolates towards various antibiotics
Antibiotic"

% Susceptible

% Intermediate

% Resistant

EM
AM
TC
TS
GP
LE

74.0
90.0
69.0
37.0
32.0
58.0

5.0
0.0
0.0
5.0
10.0
37.0

21.0
10.0
31.0
63.0
58.0
5.0

45

"EM .~ r y t h ~AM
~ .
~b p~i c ~
i l l i n ;~ TC
; .~
~
~TS .~~ ~ i ~ ~
prim/Sulphamethoxazole; GP - Grepafloxacin; LE - Levofloxacin

Example 7
Test for Inhibition Against E. coli 0157:H7 in
Rumen Fluid and Manure
Nineteen isolates, selected from the previous screening
methods, were further tested for their antagonistic action
against strains of E. coli 0 1 57:H7 that were resistant to
nalidixic acid. E. coli 0157:H7 strains were selected for
nalidixic acid-resistance to facilitate their recovery on the
media during the interaction studies and to prevent background microflora from manure and rumen.

(1) Selection of Nalidixic Acid-resistant Strains of E. coli
0157:H7:
The E. coli 0157:H7 strains that were used in the initial
inhibition study using agar spot test were selected for
nalidixic acid-resistance. MacConkey Sorbitol agar (MSA)
(Difco) was prepared supplemented with the following
concentrations of nalidixic acid (ICN Biomedicals Inc.,
Aurora, Ohio: 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4, 12.0, 8.0, 25,
and 50 pglrnl). About 0.1 ml of a well-grown overnight
culture of each E. coli 0157:H7 strain was placed into
separate petri dishes and overlaid with MSA containing 0.1
pglml of nalidixic acid. The plates were incubated at 37' C.
for 18 hours. About 3-5 well-isolated colonies were then
transferred to TBS, supplemented with 0.1 pglml nalidixic
acid, and incubated further at 37' C. for 18 hours. The cells
grown in TSB with 0.1 pglml nalidixic acid were then
overlaid with MSA containing 0.2 pglml of nalidixic acid.
The entire process was repeated with increasing concentrations of nalidixic acid in the media each time until cells were
selected that were resistant to 50 pglml of nalidixic acid.

(2) Antagonistic Action of Cattle Isolates Against E. coli
0157:H7 in Manure:
A fresh overnight culture of each selected cattle isolate
50 was prepared in 10 ml of MRS broth. Freshly prepared
strains
of nalidixic acid-resistant
~ ~ tculture
h ~~ . of
l each
i of ~the four
~
;
E. coli 0157:H7 was inoculated into 10 ml of TSB and
incubated for 18 hours at 37' C. A cocktail was prepared
from all four strains by mixing them together. Manure
55 sample of cattle was obtained from the Animal Science
Department, UNL, on the day of the experiment and about
20 g was reserved for uninoculated control. The uninoculated control was used to make sure that no bacteria (that
mav be resistant to nalidixic acid) other than the E. coli
60 0157:H7 strains added to the samples were being recovered
on MSA supplemented with nalidixic acid. About 400 grams
of manure sample was inoculated with 0.4 ml of E. coli
01 57:H7 cocktail to obtain a population of x105 CFUlml
which was divided into 20 sterile whirl pack bags (20
65 each), ~~~~i~~ one manure sample for inoculated control,
each of the other samples was inoculated with 2 ml(1 X 107
CFUlml) of the fresh MRS broth cultures of LAB (1
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isolatelmanure sample). Each of the samples thus obtained
were incubated at 37' C. and plated in duplicates on MSA
supplemented with nalidixic acid (50 pglml) at 0, 24 and 48
hours to monitor E. coli 0157:H7 growth. The pH of each
manure sample was recorded at 0, 24, and 48 hours, The
entire experiment was repeated three times.

log,, CFUlml to 1.0 log,, CFUlml). No change in pH was
observed for any of the treatments, with pH values ranging
between 6.0-6.3.
In order to be able to select final strains for the CEP,
isolates were also compared against each other for inhibition
towards E. coli 0157:H7. None of the strains were different
from each other in their inhibition against E. coli in manure.
However, in the rumen fluid it was found that at 24 hours,
strains H27, M35 (ATCC accession no. PTA-5249) andA43
were most inhibitory towards E. coli 0157:H7 compared to
the other strains whereas at 48 hours, strains C314, M38,
A46, L411 and R44 along with the aforementioned strains
also showed significant reduction in E. coli counts when
compared to the rest of the strains(PS0.05). Uninoculated
manure samples were also plated at each incubation period
to make sure no background microflora, that may be misinterpreted as E, coli 0157:H7, was being recovered on
MSA supplemented with nalidixic acid, No bacterial growth
was observed on any of the uninoculated control MSA
plates,

5

(3) Antagonistic Action of Cattle Isolates Against E. coli
0 1 57:H7 in Rumen Fluid:
rumen conditions, as per the method used by 10
T~
de Vaux et al,, Displacement of Escherichia coli 0157:H7
from rumen medium by prebiotic sugars, Appl, Environ,
Microbial, (in press), fresh bovine
fluid obtained
from theAnimal Science Dept,, UNL, was mixed with glL
15
corn starch, 2 glL maltose and equal parts of phosphate
buffer
(272 m1 of 0'2M Na2HP04 (Fischer Scientific) and 12' m1 of 0.2M NaH2P04 (Fischer Scientific)
mixed together). The mixture was sterilized and put in an
anaerobic jar to facilitate thorough reduction for 1-4 days. 20
~ f t e reduction,
r
about 10 ml of rumen fluid mixture was
Analysis of Variance (ANOVA) on the data for interaction
reserved as uninoculated with 0.25 ml of E. coli 0157:H7
studies in manure and rumen fluid were performed as a
cocktail as prepared in the manure experiment. The inocu~
~
~complete
d
~
l ~~~~i~~
~ i (RCBD)
~~ k ~
using dsingle
lated mixture was divided into 20 sterile tubes (10 ml each)
factor Repeated Measures Analysis of Statistical Analysis
and keeping one sample for inoculated control, the other 25 System software (SAS Institute Inc., Cary, N.C.). The means
samples were inoculated with 1 ml of freshly prepared
of duplicate plate counts were converted to a log,, CFUlml
cultures of selected LAB (1 isolate per sample). Each of the
scale before analysis. The treatment design was a 20x3
factorial with each plate count as a sampling unit and
samples were anaerobically incubated at 37' C. and plated
in duplicate on MSA supplemented with nalidixic acid at 0,
duplicate plate counts as an experimental unit. Differences
24 and 48 hours to monitor E. coli 0157:H7 growth. The pH 30 among treatment
were determined using LSD (Least
of all rumen-fluid samples was recorded at 0, 24 and 48
Square Difference) msthod.
hours. The entire experiment was repeated three times.
Based on the results from interaction studies in manure
The interaction of E, coli 0157:H7 with the selected LAB
and rumen fluid, bile tolerance, storage stability and idenwas studied in the manure and rumen fluid at 0, 24 and 48
tification profiles, the strains that were finally selected to be
accession
PTA-5249)
as CEP were, M35
hours. As expected, none of the strains were different from 35
and L411. These two strains were selected for the following
the control in their inhibition against E, coli 0157:H7 at
reasons: both showed significant inhibition towards E. coli
hours in both rumen fluid and manure.
0157:H7 in laboratory media (6.1 and 2.0 mm inhibition
Results from the interaction studies in manure showed
zones for M35 (ATCC accession no, PTA-5249) and L411
that at 24 hours, control (no LAB added) showed an increase 40 respectively), manure and
fluid (completely elimiinE. "li
counts
a ~ ~ r o x i m a t2.0
el~
loglo
nated E, coli at 48 h); both showed increased growth under
from 5.9 to 7.6 loglo CFU1ml
and
3).
all bile conditions at all incubation periods; the API system
strains except H27, T21, 133, 037, P31, P32 and B41
revealed good identification for both isolates; and antibiotic
(Pe0.05) reducedE. "li counts ( a ~ ~ r o x i m a t e l ~ susceptibility tests showed that M35 (ATCC accession no,
at 24 hours.
loglo
45 PTA-5249) was susceptible to all the antibiotics to which it
ever, at 48
strains 1212, C312, C314, C315, M35
was tested, while L411 was susceptible to 4 of the 6
accession
PTA-5249), A46 and L411 were
antibiotics tested. Although strain L411 was resistant to two
to maintain the reduction in E. coli 0157:H7 counts and the
antibiotics (TS and GP), the reason for its selection over
difference was
significant (Pe0.05) when
other strains is that the rest of the strains did not meet more
pared to the control. These strains were able to reduce E. coli 50 than one selection criteria when
to L41 The
0157:H7 numbers from approximately 6.0 log,, CFUlml to
selection process is summarized in Table
4.6 log,, CFUlml over a 48 hour period. No change in pH
of the treatment samples was observed at 0, 24 or 48 hours,
TABLE 6
as it ranged between 6.1-6.8 at all incubation periods.
Growth of E. coli 0157:H7 (log,,
Interaction studies in rumen fluid revealed that at 24 55
CFUIml) in association with cattle
hours, strains H27, T21, T28, C314, M35 (ATCC accession
isolates in manure at 0, 24 and 48 hours
no. PTA-5249), M38, A43, A46, L411 and R44 significantly
(Pe0.05) reduced E. coli counts (between 1 to 4 log,,
Sample
API
oh
24h
48h
reductions) compared to the control (see Table 7 and FIG. 4).
5.9
7.6
6.6
Strain M35 (ATCC accession no. PTA-5249) completely 60
P_acidilactici
5.9
6.5
4.9
eliminated E. coli 0157:H7 at 24 hours by reducing the
A46
L. acidophilus
5.9
5.9
5.2
numbers from 5.6 log,, CFUlml to 1.0 log,, CFUlml. At 48
C314
L. acidophilus
5.9
5.8
4.9
hours all of the strains except 1212, C312, C315, 037, P32
M35
L. acidophilus
6.1
5.6
4.8
M38
L. acidophilus
6.0
6.4
5.5
and B41 significantly inhibited E. coli 0157:H7 compared
L.acidophilus
5.8
5.9
5.9
S310
to the control (Pe0.05). Strains H27, C314, M35 (ATCC 65
B41
L
,
+
~
~ 6.0~
~ 6.5 ~
~ 5.7~
accession no. PTA-5249), M38, A43, A46, L411, and R44
R44
L. acidophilus
6.2
6.3
5.8
eliminated E. coli in rumen fluid at 48 h (reduction from 5.5

El5

TABLE 6-continued

TABLE 8-continued

Growth of E. coli 0157:H7 (log,,
CFUIml) in association with cattle
isolates in manure at 0, 24 and 48 hours

IC

=

Selection of isolates for
5

competitive exclusion product

Sample

API

Oh

24h

48h

Isolate

I212
037
L411
A43
H27
P3 1
C312
T2 1
T28
I33
P32

L. salivarius
L. cellobiosus
L. acidophilus
L. acidophilus
L. delb. delb.
L. acidophilus
L. acidophilus
Leuconostoc sp.
L. acidophilus
L. brevis
L. brevis

5.8
5.9
6.2
6.1
6.1
6.3
6.1
6.2
6.0
6.1
6.2

5.9
6.5
6.0
5.9
5.9
5.7
5.4
6.0
5.4
5.6
5.8

4.9
5.4
5.8
5.5
5.5
5.4
4.6
5.6
5.1
4.8
5.0

Stability
10

Interaction

Antibiotic

Manure

Rumen

Resistance"

Storage

B41
L411

-

-

+

3
2

R44

-

+
+

+
+
+

2

M35 corresponds to ATCC accession no. PTA-5249
15 "Total number of antibiotics that an isolate was resistant to, out of the six
antibiotics that the isolates were tested for.
+ indicates a positive result for each particular selection criteria.
- indicates a negative result for each particular selection criteria.

Inoculated control
20

Example 8

TABLE 7
Identification of Strains of Ribotyping and 16s
Sequence Analysis

Growth of E. coli 0157:H7 (log,,
CFUIml) in association with cattle
isolates in m e n fluid at 0. 24 and 48 hours
25
Sample
IC
C315
A46
C314
M35
M38
S310
B41
R44
1212
037
L411
A43
H27
P3 1
C312
T2 1
T28
I33
P32
IC

=

API

oh

24h

48h

-

5.6
5.6
5.5
5.6
5.6
5.7
5.7
5.6
5.6
5.6
5.7
5.7
5.3
5.5
5.6
6.3
5.6
5.6
5.6
5.6

7.1
5.9
4.9
4.9
1.0
4.9
5.9
6.1
4.9
6.1
5.9
4.8
1.5
3.0
5.9
5.7
5.7
5.3
6.0
5.9

7.4
6.0
1.O
1.O
1.0
1.O
2.1
6.3
1.O
6.9
6.1
1.O
1.0
1.O
5.8
5.6
5.7
5.7
5.9
6.1

P acidilactici
L. acidophilus
L. acidophilus
L. acidoahilus
L. acidophilus
L. acidophilus
L. fermentum
L. acidophilus
L. salivarius
L. cellobiosus
L. acidophilus
L. acidophilus
L. delb. delb.
L. acidophilus
L. acidophilus
Leuconostoc sp.
L. acidophilus
L. brevis
L. brevis

Inoculated control

The genotypic fingerprint analysis of 13 isolates, used in
manure and rumen fluid interaction studies, was carried out
by ribotyping where total DNA of an organism, after isolation, is restricted into multiple fragments (el kb to >20 kb)
30

35

40

45

TABLE 8
Selection of isolates for
competitive exclusion product

--

3u

Isolate
Stability
H27
1212
T2 1
T28
C312
C314
C315
I33
M35
M3 8
037
p3 1
P32
S310
A43
A46

Interaction

Antibiotic

Manure

Rumen

Resistance"

Storage

-

+

4

+

+

-

o

+

-

+
+
+

-

+
-

+

+
+

4
1

-

o

+
+
+
+
+

5
2
1

-

+
+
+

o
2
2
2
2
2
0
2

+
+
+
+
+
+
+
+
+
+
+
+
-
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using restriction enzyme. The restricted fragments after
separation are subsequently hybridized with a probe targeted
to the 16S, 23s or 5 s ribosomal RNA (rRNA) genes.
Restriction bands containing copies of the rRNA genes are
then visualized and a characteristic fingerprint is obtained
based on the pattern of the band sizes. To obtain ribotyping
patterns, isolates were sent to the Laboratory for Molecular
Typing at Cornell University (Ithaca, N.Y.) as MRS agar
slant cultures.
The isolates selected after screening for inhibition
towards E. coli 0157:H7 in manure and rumen fluid were
also identified by 16s rRNA sequence analysis. In this
analysis a portion of the 16s rRNA gene of the bacteria was
amplified and sequenced, and then was compared to
sequences contained in the public database, Genbank, to
provide matches to the isolate. Samples of selected isolates
were sent as MRS agar slant cultures to the Laboratory for
Molecular Typing at the Cornell University (Ithaca, N.Y.).
The genotypic identification of the selected cattle isolates
was done using ribotyping. Isolates H27 and C314 were
reported to be similar, with C314 having 95% homology
with H27. Both isolates were identified as L. acidophilus
showing 51-60% homology with the Dupont database patterns. Isolate R44 showed 58-78% homology with L. acidophilus and 58% homology with L. amylovorus when
compared with the Dupont database. The remaining isolates

60

did not have a close match with any of the patterns in either
the Dupont or LMT database. However, isolates C312 and
T28 were found closely related to each other, sharing many

65

similar bands, with T28 showing 91% homology with C312.
Isolates M35 (ATCC accession no. PTA-5249), T21, L411,
A46, A43, 133, M38 and 037 also aligned closely together
(homology ranging from 94%-97%). Results are shown in
Tables 9, 10, and 11.

US 7,323,166 B2
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20

TABLE 9

Weimer in Isolation and characterization of acid-and biletolerant isolates from strains of Lactobacillus acidophilus. J.
Dairy Sci. 82: 23-31, 1999, with some modifications. An
overnight culture of each strain of selected LAB was prepared by growing the frozen concentrated culture in MRS
broth for 18-24 hours at 37' C. About 1 ml of the overnight
culture was inoculated into 100 ml of MRS broth and
incubated further at 37' C. for 18-24 hours. The cells were
harvested by centrifugation at 10,000xg for 10 minutes at
0-4" C. The pellets were washed once in sterile PBS and
resuspended in 100 ml of PBS to obtain a population of
lxlo9 CFUlml. Bacterial numbers were determined by
plating the cell suspension on MRS agar, using appropriate
dilutions, and incubating at 37' C. for 18-24 hours. About
1% of the cell suspension was added to a series of tubes
conta!ning 10 ml MRS broth (to obtain a population of
1x10 CFUlml) acidified with 2M HCl to pH 2, 4, 5, and 7
(nonacidified/control) and incubated in a water bath at 37'
C. The growth of the organisms for each pH value was
determined at 0, 2, 4 and 24 hours by plating on MRS agar
and incubating at 37' C. The test was repeated three times
for each isolate.

Ribotyping analysis of cattle
isolates as compared to the DuPont database
LAB Strain
Code

DuPont
Accession No.

Significant
Alignments

H27

DUP5000
DUP5001
DUP5002
DUP5000
DUP5001
DUP5002
DUP5005

L.
L.
L.
L.
L.
L.
L.

R44

YO
Homology

acidophilus
acidophilus
acidophilus
acidophilus
acidophilus
acidophilus
amylovorus

60%
52%
51%
58%
78%
58%
58%

5

lo

15

TABLE 10
Ribotyping analysis of cattle
isolates as compared to each other
LAB Strain
Code

Close
Alignment to

H27
C312
T2 1

C314
T28
A46
A43
037
I33
M35
L411
M3 8

% Homology

95%
91%
97%
97%
97%
96%
96%
95%
94%

Since M35
accession no' PTA-5249) and L411
were closely aligned together in the ribotyping patterns
obtained, on]y isolate M35 (ATCC accession no, PTA-5249)
was further identified using 16s rRNA sequence analysis.
~
~~ 3 ~(ATCC
5
l accession
~
no,
t PTA-5249).
~
,, which was
identified as L. acidophilus by the API fermentation pattern,
gave different results with the 16s rRNA analysis. Comparison of the 16s rRNA sequence of the strain with the
public database, GenBank, revealed that M35 (ATCC accessionno. PTA-5249) had significant homo lo^ to L. crispatus
(98%)
In view
the
the
M35
accession
PTA-5249) and L411
with each other in the ribotyping analysis L411 is also
speculated to be L. crispatus.

20
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TABLE 11
16s rRNA sequence analysis of M35 (ATCC accession
no. PTA-5249) as compared to GenBank Database. Table
shows the top five matches to GenBank
LAB Strain
Code

Genbank
Accession No.

Significant
Alignments

% Homology (No. of

M35

AF257097
AF277096
Y17362
AF243152
AF243158

L.
L.
L.
L.
L.

98%
98%
98%
98%
98%

crispatus
crispatus
crispatus
crispatus
crispatus

(6341644)
(6341644)
(6341644)
(6341644)
(6311643)

50

55

Example 9
Test for Acid Tolerance and Antibiotic Resistance
in LAB Selected for CEP
(1) Acid Tolerance
as CEP at the end
neisolates that were finally
of all the screening procedures were further tested for acid
tolerance using the procedure described by Chou, L. and B.

60

65

(2) Antibiotic Resistance
The isolates chosen for CEP at the end of the screening
procedures were also tested for susceptibility to vancomycin, cephalosporin (cephalothin), and polymixin B belonging to Category I, 11, and I11 respectively. Agar disc diffusion
test (BBL Sensi-Disc Antimicrobial Susceptibility Test
Discs, Benton Dickinson Microbiology Systems, Cocke~sville,Md.) was used for
testing. An Overnight
each
grown On MRS agar at 370 C.
for 18-24 hours, was used to make a direct suspension in 5
ml PBS with turbidity equivalent to the 0.5 McFarland
turbidity standard. The cell suspension was streaked on the
entire surface of a Mueller Hinton Agar plate using a sterile
swab dipped into the properly adjusted inoculum. Appropriate discs containing the antibiotic were applied to the agar
and incubated at 370 C, for 16-18 hours, After incubation,
plates were examined for inhibition zones around the discs.
Recorded zone diameters (mm) were compared to the Zone
Diameter Interpretive Chart provided with the test kit, to
examine
.
the antibiotic susceptibility of the organisms. The
isolates were considered susceptible to vancomycin, cephalosporin, or polymixin B if a zone diameter of greater than
15 mm, 18 mm, or 12 mm respectively, was observed around
the disc. The entire test was replicated three times.
Both isolates, M35 (ATCC accession no. PTA-5249) and
L411, showed increased growth at pH 4.0, 5.0, and 7.0 over
a period of 24 hours a; determined by the plate counts.
Isolate M35 (ATCC accession no. PTA-5249) showed an
increase in growth (0 to 24 h) by approximately 1.0 log,,
cycle (7.2 to 8.3 log,, CFUlml) at pH 4.0, and 2.0 log,,
cycles (6.9 to 9.2 log,, CFUlml) at pH 5.0 and 7.0. Isolate
L411 showed increased growth by approximately 2.0 log,,
cycles at pH 4.0, 5.0, 7.0. Both isolates failed to survive at
pH 2.09 as no growth was observed at 2, 4, or 24 hours.
Results shown in Table 12.
The antibiotic susceptibility test of M35 (ATCC accession
no. PTA-5249) and L411 towards vancomycin, cephalosporin, and polymixin B revealed that both isolates were
susceptible to the three antibiotics. Both the isolates exhibited zones greater than 15 mm, 18 mm, and 12 mm for
vancomycin and cephalosporin respectively.

21
TABLE 12
Acid tolerance of M35 (ATCC accession no. PTA5249) and L411 based on their growth (log,, CFUIml) at
~H2.0.4.0.5.0and7.0~t0.2.4.~d24h

Isolate

Time
Period

pH 2.0

pH 4.0

pH 5.0

pH 7.0

under anaerobic conditions. The tests in manure and rumen
fluid were replicated three times.
The mixtures of developed CEP (M35 (ATCC accession
- no. PTA-5249)) and strains from a commercial CEP were
further tested for inhibition against E. coli 0157:H7 in
manure and rumen fluid. None of the CEP mixtures (UNL,
NPC, and UNL+NPS) showed a reduction in E. coli counts
in manure over a period of 48 hours when compared to
l o control. However, in rumen fluid, UNL+NPC reduced E.
coli counts considerably at 24 hours (-2 log,, cycles) and
eliminated E. coli completely at 48 hours (reduction from
5.5 log,, CFUlml to 1.0 log,, CFUlml), whereas UNL and
NPC showed a reduction in E. coli counts only at 48 hours
15
and not 24 hours. Results shown in Table 13 and FIGS. 5 and
6.

'

Example 10
Preparation of Frozen Concentrated Cultures (FCC)
of Selected LAB
The strains finally selected as CEP cultures were grown
separately into 200 ml MRS broth at 37' C. for 24 hours.
Cells were harvested by centrifugation at 10,000xg for 10
minutes at 0' C. and pellets resuspended in 20 ml of 10%
non-fat milk solids (NFMS). About 2 ml of each culture
suspension was transferred to 2 ml vials and immediately
transferred to liquid nitrogen. After freezing in liquid nitrogen, the vials containing the FCC were stored at -70' C.

TABLE 13
20

Treatment

25
IC
UNL
NPC
UNL

M35 (ATCC accession no. PTA-5249) was further tested
for its antagonism towards E, coli 0157:H7 in manure and
fluid
u with a mixture of commercial strains of
CE microorganisms (L. acidophilus LA45, and L. acidophilus LA51) obtained from Nutrition Physiology Corporation
(NPC) (Indianapolis, Ind.). Amixture of commercial strains
(NPC) was prepared by combining together 1 ml of a 1110
dilution (1 ml FCC into 9 ml of sterile 10% NFMS) of each
strain. The UNL mixture was prepared by
combining together 1 ml of FCC of each selected LAB (M35
(ATCC accession no. PTA-5249) and L411). One of the
selected UNL strains (M35 (ATCC accession no, PTA5249)) was also combined with one of the commercial
strains (LA5 1) (1 :1) and the mixture (UNL+NPC) tested for
inhibition towards E. coli 0157:H7 in manure and rumen
fluid.
Manure and rumen fluid samples of cattle were obtained
from Animal Science Dept., UNL, and rumen fluid treated
the same way as previously described. Keeping aside 10 g
of manure or rumen sample as uninoculated control, about
40 g of the sample was inoculated with 0.04 ml of fourstrain-cocktail of nalidixic acid-resistant E. coli 0157:H7.
The inoculated sample was divided into
of
each, Reserving one
as inoculated control, each of
the other
was inoculated with 1
of UNL, NPC,
orUNL+NPC mixture, All samples were incubated at 37O C.
and E. coli growth was monitored at 0, 24, and 48 hours by
plating on MSA supplemented with nalidixic acid (50
pglml). Incubation for tests in rumen fluid was carried out

+ NPC

E. coli counts in Manure E. coli counts in Rumen Fluid
Oh

24h

48h

Oh

24h

48h

5.8
5.7
5.7
5.7

7.5
6.3
6.0
7.5

7.1
6.2
6.9
7.0

5.7
5.7
5.7
5.9

7.5
6.3
5.5
4.4

8.1
4.2
4.7
1.O

30
IC - Inoculated Control; UNL - Mixture of isolates M35 (ATCC accession
no. PTA-5249) and L411; NPC - Mixture of commercial strains LA51 and
LA45.

Example 11
Antagonistic Effect of Developed and Commercial
CEP on E. coli 0157:H7 in Manure and Rumen
Fluid

Growth of E. coli 0157:H7
(log,, CFUIml) in association with competitive
exclusion rodupts in manure and rumen fluid

Example 12
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Test for Interaction Among LAB
40

45

50

55
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The
strains
as CEP (M35
accession
no. PTA-5249) and L411) and the commercial strain (LA51)
used in the interaction studies above were further tested for
inhibition against each other using the agar spot test. An
overnight culture of M35 (ATCC accession no. PTA-5249),
L411 or LA5 1 in MRS broth was spot-induced on MRS agar
plate and incubated for 24 hours at 370 C, in
bags
flushed with CO, for 30 seconds. About 1 ml of an overnight
culture of each strain was inoculated individually into 10 ml
MRS agar (Difco) to obtain a
'Oncentration of approximately 5 x 1 0 ~CFUlml. This mixture was then
poured onto the surface of s~ot-inoculatedagar plates that
contained well-grown colonies of test bacteria. After 24
hours of incubation at 37' C. inhibitory activity was measured as the size of inhibition zones around the colony.
Inhibition was considered positive if the width of the clear
zone around the colonies was 20.5 mm. The test was
repeated three times,
The LAB used in CE mixtures were also tested for
antagonism against each other using the agar spot test. As
the results indicated (Table 141, both isolates, M35 (ATCC
accession no. PTA-5249) and L411, were being inhibited by
LA51, while isolates M35 (ATCC accession no. PTA-5249)
and L411 were inhibiting each other. However, neither of the
two cattle isolates (M35 (ATCC accession no. PTA-5249)
and L411) showed any antagonistic effect against LA5 1.

qf

US 7,323,166 B2
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TABLE 14
Inhibition of lactic acid
bacteria (M35 (ATCC accession no. PTA-5249), L411, and
LA51) towards each other using agar spot test
Idibitin Isolates

5

Zone of Inhibition (mm)
Test Isolates
M35
L411
LA5 1

LA5 1

L411

M35

1.40
1.27

0.99

-

-

-

0.00

10
1.27
0.00

Example 13
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Live Animal Studies
One hundred
(IX5) steers
British
breeding (primarily Angus, Hereford, and Angus Herewere purchased through
Industries, Inc. and
to the Texas Tech University Burnett Center.
Following arrival, the cattle were unloaded and processed.
Processing included: 1) individual body weight (BW) measurement; 2) uniquely numbered ear tag in the left ear; 3)
vaccination with Ultrachoice 7 (Pfizer Animal Health; Lot
NO. S900024 Exp. J u ~5,2001
.
and Lot NO. S903222B Exp.
Sep. 10, 2001); 4) vaccination with Bovishield 4+Lepto
(Pfizer Animal Health; Ser. No. SNA019266lA013371 Exp
Oct. 1, 2002; Ser. No. SNA018354lA019248 Exp. Sep. 11,
2002); and 5) treatment down the back line with Dectomax
(Pfizer Animal Health; Lot No. K9T04911 Exp. July, 2002).
Steers were sorted to 37 concrete, partially slotted floor pens
with five steers per pen and offered 10 lblsteer of a 65%
concentrate starter diet. On Jun. 6, 2001 all cattle switched
to a 70% concentrate diet, and the switch to an 80%
concentrate diet occurred on Jun. 11, 2001.
All cattle were weighed
- on Jun. 12, 2001 to initiate the
preliminary phase of the experiment, At this time, each steer
was implanted with Revalor
Lot No, 321 Exp,
2002) in the right ear. Pen assignments were
retained from the original sdrt that had occurred at the time
of arrival processing, on J ~ 16,
, 2001 all cattle were
switched to the final 90% concentrate diet ( ~ ~ 1).b ~~~h
l ~
steer was weighed on Jul. 31, 2001 (49 d on feed), and an
individual fecal sample was obtained to test for shedding of
E. coli 0157:H7.
Treatment and Pen Assignments. Five steers (one with
injured foot, one with an injured shoulder, one that did not
gain BW for the first 49 d, and the two steers of lightest BW
among the remaining cattle) were designated as extra cattle,
leaving 180 steers for the experiment.
Each steer was weighed on Aug. 14, 2001 to begin the
study. Treatments (control and the two Lactobacillus acidophilus cultures) were applied when the cattle were fed after
they were returned to their pens.
The
was a randomized
with pen as the
unit (I2 pens per each
the three treatments with five steers per pen for a
180 steers). The three treatments were as follows:
Control standard TTU Burnett Center 90% concentrate
diet with carrier (lactose) only mixed in water and added to
the diet at the time of feeding;
NP 747 standard TTU Burnett Center 90% concentrate
diet with 1 x 1 0 ~CFU Lactobacillus acidophilus Strain NPC

20

747 (provided by University of Oklahoma) mixed in water
and added to the diet at the time of feeding;
NP 750 standard TTU Burnett Center 90% concentrate
diet with 1 x 1 0 ~CFU Lactobacillus acidophilus Strain NPC
750 (isolate M35 (ATCC accession no. PTA-5249)) mixed in
water and added to the diet at the time of feeding.
Each treatment culture (lactose for the control treatment)
was prepackaged in aluminum foil packets by personnel of
Nutrition Physiology Corp., Indianapolis, Ind. The contents
of one packet were sufficient to supply the desired dose of
microbial culture for the 12 pens of cattle on each treatment.
The contents of the packet for each treatment were mixed
with 2.5 L of distilled water in a plastic sprinkler can, after
which the contents of the sprinkler can were poured onto the
diet as it mixed in a Rotomix 84-8 mixerldelivery unit.
Experimental Diets. Ingredient composition of the 90%
concentrate diet fed during the experiment is shown in Table
15. These data reflect adjustments for the average
- dry
. matter
(DM) matter content of feed ingredients for the period
during which microbial culture treatments were applied,
Each diet contained the same intermediate premix (Table
15), which supplied protein, various minerals and
Rumensin (30 g/ton, DM basis), and Tylan (8 g/ton, DM
basis),

25

TABLE 15
Ingredient composition (%, DM basis)
of the 90% concentrate experimental diet
30

35

Ingredient
Alfalfa hay, ground
Cottonseed hulls
Steam-flaked corn
Dry-rolled corn
Cottonseed meal
Molasses
Fat (yellow grease)
Urea
Premix"

Percentage of DM
4.96
5.04
64.60
10.15
4.82
4.12
2.93
0.90
2.48

40 "Composition of the premix was as follows: cottonseed meal = 23.9733;
high-calcium limestone = 42.1053; dicalcium phosphate = 1.0363; potassium chloride = 8.000; magnesium oxide = 3.5587; ammonium sulfate =
6.6667: salt = 12.000: cobalt carbonate = 0.0017:, coooer sulfate = 0.1572:
iron sulfate = 0.1333;EDDI = 0.0025; manganese oxide = -0.2667; sele-'
nium premix, .2% Se = 0.1000; zinc sulfate = 0.8251; vitamin A, 650,000
45 IU/g = 0.0122; vitamin E, 275 IU/g = 0.1260; Rumensin, 80 mg/lb =
0.6750; and Tylan, 40 mg/lb = 0.3600. Concentrations by the certain
ingredients are on a 90% DM basis,
L L
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Procedures and Data Collection. Standard procedures at
the Burnett Center were used throughout the
The three treatment diets were mixed in a 45-cubic foot
paddle mixer. The Burnett Center feed
system is
a
batching system. A printout of the weight of each dietary ingredient was recorded on a daily ingredient usage output from
the computerized batching system. Once the total amount of
feed for a given treatment was mixed, the mixed batch was
released from the Marion paddle mixer and delivered by a
drag-chain conveyer to a Rotomix 84-8 delivery system.
After feed was delivered, and the mixer unit for the Rotomix
84-8 unit was operating, the contents of the
can for
a given treatment were poured onto the diet, After
for
approximately 4 to 5 min, the quantity of feed allotted to
each of the 12 pens within treatment was then weighed to the
nearest 1 lb by use of the load cells and indicator on the
Rotomix 84-8 unit. Feeding order of treatment diets
throughout the experiment was Control, NPC 747, and NPC
750. Clean-out of the Rotomix 84-8 was monitored closely

US 7,323,166 B2
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to avoid cross-contamination of diets, and at least one batch
of a diet from another experiment (equivalent to the Control
diet) was mixed between the NPC 747 and NPC 750
treatment diets.
Dry matter determinations on ingredients used in the
experimental diets were made every 2 wk throughout the
experiment. These ingredient DM values were used to
calculate the DM percentage of each dietary ingredient
during the experiment,
addition, samples of mixed feed
delivered to feed bunks were taken weekly throughout the
experiment. These bunk sample DM values were used to
compute average DM intake (DMI) by the cattle in each pen.
Samples of feed taken from the bunk were composited for
the entire preliminary period and for each interval in which
cattle were weighed (typically 28-d intervals) after the
microbial culture treatments were initiated. Composited feed
samples were ground to pass a 2-mm screen in a Wiley mill
and analyzed for DM, ash, crude protein (CP), acid detergent
fiber (ADF), Ca, and P (AOAC, 1990).
Each feed bunk of the 36 pens was evaluated daily. The
of feed remaining in each bunk was estimated, and
the suggested daily allotment of feed for each pen was
recorded. This bunk-reading process was designed to allow
for little or no accumulation of unconsumed feed (0 to 1 lb
Per pen). A computer printout of the intake by each Pen for
the previous 3-d period was available each morning to assist
with bunk reading. Pens of cattle that maintained a given
level of feed intake for a 3-d period were challenged to
consume a higher level (0.4 lblsteer challenge). Each challenge level was maintained for a 3-d period when the pen
accepted the challenge and consumed all the feed offered.
The ultimate goal of the challenge process was to ensure that
the cattle were consuming the maximum quantity of feed
possible. Feed bunks were cleaned, and u n ~ ~ n s u m efeed
d
was weighed (Ohaus electronic scale, 20.1 lb) at intervals
corresponding to intermediate weigh dates throughout the
trial. Dry matter content of these bunk weigh back samples
was determined in a forced-air oven by drying
(typically 20 h) at 100' C. All weights for DM determinations were obtained on an Ohaus electronic balance (20.1 g).
The DM1 by each pen was calculated by multiplying the DM
content of the delivered feed by the total feed delivery to
each Pen, with ~~i-rection
for the DM of any feed weighed
back from each pen.
Statistical Analyses. All performance data were analyzed
with pen as the experimental unit. A complete randomized
block design was employed, and computations were made
with the GLM procedure of SAS (1987). Pen means for
daily gain (ADG) and average daily DM1 were included in
the data file, and feed:gain ratio was computed as the
quotient of daily DM1 divided by ADG. The effect of
treatment and block were included in the model for penbased data.
Microbiological Measurements Monitored. Fecal samples
were taken directly from the rectum of the animal initially
and every 28 d thereafter until they received probiotic
supplementation. Following probiotic supplementation,
fecal samples were taken every 14 d. A newly developed
assay for the detection of E. coli 0157:H7 was used to detect
the organism in this study (modification of Elder, R, O,, J,
E. Keen, G. R. Siragusa, G. A. Barkocy-~allagher,M,
Koohmarie, and W. W. Lagreid. 2000. Correlation of enterohemorrhagic ~ ~ ~ hcoli~0 1~5 7 :i ~ prevalence
7~ h i in
~ feces,
hides, and carcasses of beef cattle during processing. Proc.
Natl. Acad. Sci. 97: 2999-3003). This method is very sensitive and will detect E. coli 0157:H7 when numbers are
very low. The method was originally developed at the Meat

Animal Research Center in Clay Center, NE. Briefly, ninety
milliliters of GN-VCC broth were inoculated with 10 g of
feces (GN-VCC is GN broth with 8 mglmL of vancomycin,
50 ng/mL of cefixime and 10 mglmL of cefsulodin) and
incubated for 6 at 370 C, E, coli cells were subjected to
immunomagnetic separation by mixing 1 mL of the culture
above with 20 of D ~ n a l
beads for 30 min at room
temperature. Beads were washed three times in PBS-Tween
20 and 50 mL of the bead-bacteria mixture were spread on
to CT-SMAC plates
containing 50 ng/mL of
cefixime and 2.5 uglmL of tellurite) and streaked for isolation. Plates were incubated overnight at 37O C. Three sorbitol-negative colonies were picked and streaked for isolation on CT-SMAC (to verify purity of colony selection).

5

lo

15

Plates were incubated overnight at 370 C, A single colony
from the CT-SMAC plate above was selected and inoculated
into MacConkey agar, Fluorocult agar, and MacConkey
20

25

broth. Broth was incubated overnight at 370 C. MUGnegative, lactose-positive colonies were selected, and
indole, TSI, and VP tests were conducted on selected ~010nies. Colonies that were indole-positive, MA, or KIA plus
gas and VP-negative were boiled (using cells from the
MacConkey broth above) and tested for the 0 1 57 antigen
using a ~~~~l latex agglutination kit, colonies were subcultured on to blood agar, The H7 agglutination andAPI 20
tests were conducted on 0157-positive cells for confirma-
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Results. Upon arrival at the feedlot, only three of the
animals had detectable amounts of the pathogen. Just before
probiotic supplementation, 24 of the animals had detectable
amounts of the pathogen in fecal grab samples. These
were distributed equally among the three treatment
AS FIGS. 7 and 8 show, both individual animal samples
and Pen samples taken 14 and 28 days following the start of
the treatment indicate that NPC 750 and NPC 747 significantly reduced shedding compared to the control treatment.
Early in treatment (day 14) NpC 750 was more effective at
reducing shedding than NPC 747. On day 42, there were
significant differences for individual animal samples but not
for pen data, Again, when looking at individual samples,
shedding was reduced in NPC treatment groups compared to
the COntrO1 group.
Analyzed nutrient content of the 90% concentrate diet fed
during the treatment period was generally in close agreement with formulated values. Averaged over the treatment
feeding period, the diet contained (DM basis) 12.69% CP,
4.5% ash, 8.82% ADF, 0.56% Ca, and 0.30% P.
Average daily gain (Table 6) did not differ among
treatments (P>O,lO), but cattle in both the Lactobacillus
culture groups had numerically higher ADG for the first 28
d of the treatment feeding period. In addition, cattle in the
NPC 747 andNPC 750 treatments tended (P50.144) to have
adjusted
BW)
greater adjusted ADG
for the overall study than control cattle. ~ r matter
y
intake
did not differ among treatments (P>0.10) for the first 28 d or
for the overall treatment period. Similarly, feed:gain ratio
did not differ (P>0.10) for the first 28 d or for the ~verall
period; however, feed:gain ratio based on adjusted ADG
tended (P50.067) to be improved for the two probiotic
culture treatments than for the control.
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TABLE 16

What is claimed is:
1.A composition comprising a biologically pure, isolated
Lactobacillus acidophilus strain ATCC accession Number
PTA-5249,
wherein said strain inhibits Escherichia coli 0157:H7;
wherein said strain is resistant to from 1 to 4 antibiotics
selected from the group consisting of erythromycin,
tetracycline, ampicillin, grepafloxicin, levofloxacin, tri-

Effects of live cultures of
Lactobacillus acidophilus Strains NPC 747
and NPC 750 on performance by finishing beef steers
Treatment
Item
Initial BW, ~b
Final BW, Ib
Adjusted final BW, Ib'
Daily gain, Ib
d o to 28
d 0 to end
Adjusted 0 to end'
DMI, bllsteer

ail^

d 0 to 28
d 0 to end
Feed: gain
d o to 28
d 0 to end
Adjusted d 0 to end

Control (C)

NPC 747

NPC 750

SE"

1,037.2
1,277.1
1,272.1

1,029.1
1,271.5
1,276.4

1,029.6
1,283.4
1,283.4

2.38
6.90
7.69

4.07
3.50
3.44

4.28
3.49
3.58

4.33
3.65
3.69

0.150
0.101
0.106

20.02
20.54

20.29
20.32

20.36
20.85

0.264
0,249

4.94
5.94
6.01

4.84
5.92
5.75

4.73
5.76
5.66

0.133
0.116
0.127

control = standard T.U. Burnett Center 90% concentrate diet with carrier
(lactose) only mixed in water and added to the diet at the time of feeding;
19g CAU Lactobacillus acidophilus Strain NPC
NOC 747 = Control
747 per animal; NPC 750 = Control + 1 x log CAU Lactobacillus acidohilus Strain NPC per animal. Average days on feed = 70.
q o o l e d standard error of treatment means, n = 12 pens per treatment
'Adjusted final BW was calculated as follows: (Hot carcass weightlaverage dress of 62.41%). Adjusted daily gain was calculated as follows: (Adjusted final BW - initial BW)/days on feed. Adjusted feed:gain was the
ratio of daily DM1 and adjusted daily gain.
+

10

methoprim-sulfamethoxazole, vancomycin, cephalothin and polymyxin B, and

15

wherein the inhibition occurs in the ruminal fluid and
manure of cattle.
2. The composition of claim 1,wherein said Escherichia
coli 0157:H7 is nalidixic acid-resistant.

20

3. The composition of claim 1, wherein said strain is
tolerant to bile.

4. The composition of claim 3, wherein the bile is oxgall.
25

30

5. The composition of claim 1, wherein said strain will
remain viable when exposed to an environment maintained
at 0" C.
6. The composition of claim 5, wherein said exposure is
for three months,

* * * * *

